Validation of spectrophotometric assays for serum paraoxonase type-1 measurement in dogs

American Journal of Veterinary Research

Volumn 73, Issue 1, 2012, Pages 34-41

  Tvarijonaviciute, Asta ^a   Tecles, Fernando ^a   Caldin, Marco ^b   Tasca, Silvia ^b   Cerón, José ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b San Marco Veterinary Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; BIOLOGICAL MARKER; EDETIC ACID;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; MALE; NONHUMAN; SPECTROFLUOROMETRY; VALIDATION PROCESS;

ACETATES; ANIMALS; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; CARBOXYLIC ESTER HYDROLASES; DOGS; FEMALE; MALE; NITROPHENOLS; OXIDATIVE STRESS; PHENOLS; SPECTROPHOTOMETRY;

ANIMALIA; CANIS FAMILIARIS;

EID: 84855274283     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.73.1.34     Document Type: Article

References (36)

1. Mackness MI, Arrol S, Durrington PN. Paraoxonase prevents accumulation of lipoperoxides on low-density lipoprotein. FEBS Lett 1991; 286: 152-154.
2. Marsillach J, Aragonès G, Beltrán R, et al. The measurement of the lactonase activity of paraoxonase-1 in the clinical evalua- tion of patients with chronic liver impairment. Clin Biochem 2009; 42: 91-98.
3. Ciftci H, Savas M, Yeni E, et al. Serum paraoxonase activ- ity in patients with low glomerular filtration rates. Ren Fail 2010; 32: 562-565.
4. Dong JT. Prevalent mutations in prostate cancer. J Cell Biochem 2006; 97: 433-447.
5. Dullaart RP, Vries R, Sluiter WJ, et al. High plasma C-reactive protein is related to low paraoxonase-I activity independently of high leptin and low adiponectin in type 2 diabetes mellitus. Clin Endocrinol 2009; 70: 221-226.
6. Mackness B, Mackness MI, Arrol S, et al. Serum paraoxonase 55 and 192 polymorphism and paraoxonase activity and concen- tration in non-insulin dependent diabetes mellitus. Atheroscle- rosis 1998; 139: 341-349.
7. Kotani K, Sakane N, Sano Y, et al. Changes on the physiological lactonase activity of serum paraoxonase 1 by a diet intervention for weight loss in healthy overweight and obese women. J Clin Biochem Nutr 2009; 45: 329-334.
8. Ferretti G, Bacchetti T, Moroni C, et al. Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females. J Clin Endocrinol Metab 2005; 90: 1728-1733.
9. Mackness M, Durrington P, Mackness B. Paraoxonase I activ- ity, concentration and genotype in cardiovascular disease. Curr Opin Lipidol 2004; 15: 399-404.
10. Kujiraoka T, Oka T, Ishihara M, et al. A sandwich enzyme- linked immunosorbent assay for human serum paraoxonase concentration. J Lipid Res 2000; 41: 1358-1363.
11. Himbergen TM, Roest M, Graaf J, et al. Indications that paraox- onase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia. J Lipid Res 2005; 46: 445-451.
12. Khersonsky O, Tawfik DS. Chromogenic and fluorogenic assays for the lactonase activity of serum paraoxonases. Chembiochem 2006; 7: 49-53.
13. Motta S, Letellier C, Ropert M, et al. Protecting effect of vitamin E supplementation on submaximal exercise-induced oxidative stress in sedentary dogs as assessed by erythrocyte membrane fluidity and paraoxonase-1 activity. Vet J 2009; 181: 288-295.
14. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004; 37: 277-285.
15. Haagen L, Brock A. A new automated method for phenotyping arylesterase (EC 3.1.1.2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clin Biochem 1992; 30: 391-395.
16. Browne RW, Koury ST, Marion S, et al. Accuracy and bio- logical variation of human serum paraoxonase 1 activity and polymorphism (Q192R) by kinetic enzyme assay. Clin Chem 2007; 53: 310-317.
17. Martinez-Subiela S, Ceron JJ. Effects of haemolysis, lipaemia, hyperbilirubinemia, and anticoagulants in canine C-reacive protein, serum amyloid A, and ceruloplasnib assays. Can Vet J 2005; 46: 625-629.
18. Draganov DI, Teiber JF, Speelman A, et al. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. J Lipid Res 2005; 46: 1239-1247.
19. Tor ER, Holstege DM, Galey FD. Determination of cholines- terase activity in brain and blood samples using a plate reader. J AOAC Int 1997; 5: 1308-1313.
20. Huen K, Richter R, Furlong C, et al. Validation of PON1 en- zyme activity assays for longitudinal studies. Clin Chim Acta 2009; 402: 67-74.
21. Dantoine TF, Debord J, Charmes JP, et al. Decrease of serum paraoxonase activity in chronic renal failure. J Am Soc Nephrol 1998; 9: 2082-2088.
22. Jayakumari N, Thejaseebai G. High prevalence of low serum paraoxonase-1 in subjects with coronary artery disease. J Clin Biochem Nutr 2009; 45: 278-284.
23. Alleman AR. The effects of haemolysis and lipaemia on serum biochemical constituents. Vet Med 1990; 85: 1272-1284.
24. Parra S, Marsillach J, Aragones G, et al. Methodological con- straints in interpreting serum paraoxonase-1 activity measure- ments: an example from a study in HIV-infected patients. Lipids Health Dis 2010; 9: 32-36.
25. Mackness MI, Mackness B, Durrington PN, et al. Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 1996; 7: 69-76.
26. Mackness I. Why plasma should not be used to study paraox- onase? Atherosclerosis 1998; 136: 195-196.
27. Ham TH, Grauel JA, Dunn RF, et al. Physical properties of red cells as related to effects in vivo. IV. Oxidant drugs producing abnormal intracellular concentration of haemoglobin (eccen- trocytes) with a rigid-red-cell haemolytic syndrome. J Lab Clin Med 1973; 82: 898-910.
28. Chan TK, Chan WC, Weed RI. Erythrocyte hemighosts: a hallmark of severe oxidative injury in vivo. Br J Hematol 1982; 50: 575-582.
29. Harvey JW, Rackear D. Experimental onion-induced haemolytic anemia in dogs. Vet Pathol 1985; 22: 387-392.
30. Caldin M, Carli E, Furanello T, et al. A retrospective study of 60 cases of eccentrocytosis in the dog. Vet Clin Pathol 2005;34:224-231.
31. Harvey JW. Pathogenesis, laboratory diagnosis, and clinical im- plications of erythrocyte enzyme deficiencies in dogs, cats, and horses. Vet Clin Pathol 2006; 35: 144-156.
32. Pavlica Z, Petelin M, Nemec A, et al. Measurement of total antioxidant capacity in gingival crevicular fluid and serum in dogs with periodontal disease. Am J Vet Res 2004;65:1584-1588.
33. Camkerten I, Sahin T, Borazan G, et al. Evaluation of blood oxidant/antioxidant balance in dogs with sarcoptic mange. Vet Parasitol 2009; 161: 106-109.
34. Selec S, Aslan M, Horoz M, et al. Oxidative status and se- rum PON1 activity in beta-thalassemia minor. Clin Biochem 2007; 40: 287-291.
35. Ferré N, Camps J, Prats E, et al. Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage. Clin Chem 2002; 48: 261-268.
36. Novak F, Vavrova L, Kodydkova J, et al. Decreased paraox- onase activity in critically ill patients with sepsis. Clin Exp Med 2010; 10: 21-25.